1,312
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Emodin inhibits ATP-induced IL-1β secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X7 receptor

, , , &
Pages 51-57 | Received 27 Feb 2013, Accepted 23 May 2013, Published online: 12 Sep 2013

Abstract

Context: Previous in vitro studies have demonstrated that emodin (1,3,8-trihydroxy-6-methyl-anthraquinone), an anthraquinone derivative from the rhizome of Rheum palmatum L., can inhibit the activation of P2X7 receptors (P2X7R) as a potential antagonist. However, the effects of emodin on P2X7R-related inflammatory processes remain unclear.

Objective: This study aimed to investigate the effects of emodin on different inflammation responses of macrophages induced by ATP, the natural ligand of P2X7R.

Materials and methods: Rat peritoneal macrophages were treated with millimolar ATP and emodin (0.1, 0.3, 1, 3, 10 µM) or brilliant blue G (BBG, 0.1, 1, 10 µM). Cytosolic Ca2+ concentration ([Ca2+]c) was detected by fluorescent Ca2+ imaging. Interleukin-1β (IL-1β) release was measured by rat IL-1β ELISA kits. Reactive oxygen species (ROS) generation was examined by dihydroethidium (DHE) fluorescent staining. Phagocytic activity was tested by neutral red uptake assay.

Results: We found that the [Ca2+]c increase evoked by ATP (5 mM) was inhibited by emodin, in a dose-dependent manner with IC50 of 0.5 μM. Furthermore, emodin reduced the IL-1β release induced by ATP (2 mM) in lipopolysaccharide (LPS)-activated macrophages, with an IC50 of 1.6 μM. Emodin also strongly suppressed the ROS production and phagocytosis attenuation triggered by ATP (1 mM), with IC50 values of 1 μM and 0.7 μM, respectively. Besides, BBG, a specific antagonist of P2X7R, exhibited similar suppressive effects on these inflammation responses.

Conclusion: These results showed the inhibitory effects of emodin on ATP-induced [Ca2+]c increase, IL-1β release, ROS production and phagocytosis attenuation in rat peritoneal macrophages, by inhibiting the activation of P2X7R.

Introduction

Besides its classic intracellular role as an energy molecule, ATP has also been recognized as an important extracellular signaling molecule participating in inflammation and tissue damage dramatically (Khakh & North, Citation2006; Ralevic & Burnstock, Citation1998). It promotes various responses including cell membrane depolarization, intracellular neuroregulator and immunoregulatory substances generation and release by activating the cell surface nucleotide receptors (P2 class) (Gu et al., Citation2010; Marques et al., Citation2011). The P2 family has been classified into two subfamilies, P2X and P2Y. The P2X receptors function as ATP-gated cation channels (White & Burnstock, Citation2006), which are highly expressed in the cells of immune system such as macrophages (Coutinho et al., Citation2005).

Macrophages are multifunctional immune cells that play a vital role in immune responses. P2X7 receptor (P2X7R), a submember of P2X receptors, is predominantly expressed in various types of macrophages participating in many immune responses and inflammatory diseases (Coutinho et al., Citation1999, Citation2005). Upon the activation of P2X7 receptor induced by its natural ligand ATP, the membrane potential of macrophages is rapidly depolarized resulting in an influx of extracellular calcium (Aga et al., Citation2004). There is abundant evidence supporting the idea that ATP can stimulate the maturation and secretion of interleukin-1β (IL-1β) in macrophages after the accumulation of pro-IL-1β caused by bacterial lipopolysaccharide (LPS) (Kahlenberg & Dubyak, Citation2004). Moreover, P2X7R-dependent Ca2+ entry and K+ efflux are believed to be necessary for this ATP-induced IL-1β processing (Ferrari et al., Citation2006). Many reports suggest that the activation of P2X7R plays a critical role in ATP-triggered reactive oxygen species (ROS) generation in macrophages (Fontanils et al., Citation2010; Moore & MacKenzie, Citation2009; Pfeiffer et al., Citation2007). Furthermore, it has been demonstrated that exposure to millimolar quantities of ATP for 30 min significantly attenuated macrophage phagocytosis resulted from the activation of P2X7R (Fang et al., Citation2009).

Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is one of the most effective constituents in the traditional Chinese herb Rheum officinale Baill (Tang et al., Citation2007), derived from the root and rhizome of Rheum palmatum L. (Tsai & Chen, Citation1992). It exerts effects on a number of biological activities including anti-inflammation, antivirus, antitumor and immunosuppression (Huang et al., Citation1991, Citation1992; Kaneshiro et al., Citation2006). According to our previous research, it has been found that emodin reduced 2′,3′-O-(benzoyl-4-benzoyl)-ATP (BzATP, a specific agonist of P2X7R)-triggered cytosolic Ca2+ concentration ([Ca2+]c) increase in macrophages and suppressed BzATP-evoked currents in human embryonic kidney (HEK) 293 cells expressing P2X7R. In addition, emodin inhibited ATP-induced formation of dye permeable pore, a hallmark property associated with the activation of P2X7R. These results provide evidence for a novel role of emodin as an antagonist of P2X7R (Liu et al., Citation2010). However, the influence of emodin on P2X7R-related inflammatory processes remained largely unclear. Therefore, the effects of emodin on ATP-evoked [Ca2+]c increase, IL-1β release, ROS production and phagocytosis attenuation in macrophages were examined in this study.

Materials and methods

Animals and reagents

Healthy male Wistar rats with weight of 200 ± 50 g were obtained from the Institute of Health and Environmental Medicine, Academy of Military Medical Sciences (Tianjin, China, Certification Number: SCXK 2010-0002). DMEM and fetal calf serum (FCS) were purchased from Gibco (Grand Island, NY) and HyClone (Logan, UT), respectively. Emodin was obtained from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Fura-2/AM was from Biotium (Hayward, CA). IL-1β ELISA kits were purchased from NeoBioscience Technology Co., Ltd. (China). Neutral red was from Damao Chemical reagent Factory (Tianjin, China). SOD (superoxide dismutase) was purchased from Beyotime Institute of Biotechnology (Haimen, China). The rest of reagents, including ATP, LPS (lipopolysaccharide), DHE (dihydroethidium), BBG (brilliant blue G), DPI (diphenylene iodonium) and DMSO (dimethylsulfoxide), were from Sigma (St. Louis, MO).

Millimolar concentrations of ATP are required for P2X7R activation (Surprenant et al., Citation1996), and the optimal concentration of ATP chosen for each experiment was based on previous reports (Fang et al., Citation2009; Zhou et al., Citation2006). The concentrations of emodin (0.1, 0.3, 1, 3, 10 μM) were selected based on our preliminary experiments and the effectual dose applied in previous studies (Kaneshiro et al., Citation2006; Tang et al., Citation2007). The specific antagonist of P2X7R BBG was set as positive control, and the doses that ranged from 0.1 to 10 μM were also chosen according to previous work (Jiang et al., Citation2000; Liu et al., Citation2010).

Macrophage isolation and culture

Rat peritoneal macrophages were isolated and cultured as previously described (Zhou et al., Citation2006). Briefly, Wistar rats were sacrificed according to institutional guidelines. Hanks’ balanced salt solution (HBSS) (NaCl 150 mM, KCl 5.4 mM, CaCl2 2 mM, MgCl2 1 mM, glucose 10 mM and HEPES 10 mM, pH 7.4) was injected into the abdomen of each rat. Peritoneal cells were isolated from the abdomen, collected by centrifugation at 200 g for 10 min and then cultured in DMEM containing 10% FCS in a humidified incubator with 5% CO2 at 37 °C before analysis. The adherent cells were used in our experiment. Nonspecific esterase staining showed that approximately 95% of them were macrophages as characterized previously.

Measurement of cytosolic Ca2+ concentrations ([Ca2+]c)

[Ca2+]c was measured as previously described (Hu et al., Citation2012). After treatment, macrophages were loaded with 2 μM fura-2/AM in HBSS for 1 h at room temperature in dark. After a gentle washing step, cells were bathed in fresh HBSS solution for monitoring the changes in [Ca2+]c triggered by ATP. [Ca2+]c was measured with a calcium imaging system built on an inverted fluorescence microscope (Olympus IX51). The ratiometric fluorescent Ca2+ indicator fura-2 was alternately excited at 340 nm and 380 nm with a Lambda 10-2 Sutter (Sutter Instrument, Novato, CA). Fluorescence images (filtered at 515 nm ± 25 nm) were acquired by a CCD camera (CoolSNAP fx-M, Roper Scientific Inc., Tucson, AZ) and analyzed with MetaFluor (Universal Imaging Corporation, Downingtown, PA). [Ca2+]c was represented by the ratio of fluorescence intensity at 340 nm/fluorescence intensity at 380 nm (F340/F380). At least three independent experiments were done for each condition. One curve of calcium changes was plotted as the representation of other similar traces.

Measurement of interleukin-1 beta (IL-1β) release

Extracellular IL-1β was detected by the rat IL-1β ELISA kit. Briefly, after treatment with indicated reagents, the supernatant of macrophages in culture in each group was transferred into an ELISA plate seeded with the IL-1β antibody, and incubated for 90 min. Then the plate was washed with the washing buffer for five times. After that, the secondary antibody was applied for 60 min and then washed extensively. Subsequently, the HRP-conjugate reagent was introduced to each well of the plate to promote the formation of antibody–antigen–enzyme–antibody compounds for 30 min. After repeated washing steps, the chromogen solution and stop solution was sequentially added into each well for an incubation step of 15 min and 5 min, respectively. Finally, the absorbance at 450 nm representing the relative level of IL-1β in each well was measured by an ELISA reader (Bio-Rad Imark Microplate Reader, Hercules, CA). The concentration of IL-1β in each group was determined by the standard curve.

Detection of intracellular reactive oxygen species (ROS)

Dihydroethidium (DHE), a reduced form of ethidium bromide, was used to detect intracellular ROS. After treatment with indicated reagents, macrophages were incubated in HBSS with 5 μM DHE for 30 min at 37 °C in dark. Then they were rinsed twice with HBSS and observed with a fluorescence microscope at the excitation wavelength of 488 nm and emission wavelength of 610 nm. The fluorescent intensity represents the intracellular ROS level.

Measurement of phagocytic activity of macrophages

The phagocytic activity of macrophages was analyzed by the uptake assay of neutral red (Man et al., Citation2012). Briefly, after the pre-incubation with emodin or BBG for 3 h, macrophages were treated simultaneously with ATP (1 mM) and neutral red (0.1%) for 30 min. After the two washing steps with HBSS, the cells were treated with lysis buffer (50% acetic acid and 50% ethanol) shaking for 15 min. The absorbance at 550 nm (A550) for each well was determined by an ELISA reader (Bio-Rad Imark, Hercules, CA). The relative phagocytic activity in each group was represented by A550, sample. The inhibition of phagocytic activity in ATP alone group was taken as 100% (control group was treated with vehicle solution), and the inhibitory rates in other groups were normalized to the ATP group and calculated as: . Thus, the recovery rates of phagocytic activity can be derived as: .

Statistical analysis

All data are presented as mean ± standard deviation (SD) from three independent experiments. The statistical comparison between two groups was carried out using Student’s t-test (Origin 8.1), and the analysis for multiple groups was using Dunnett's test (SPSS 18.0, one-way ANOVA). p < 0.05 was considered to be statistically significant. The values of half maximal inhibitory concentration (IC50) were calculated according to the dose–response curve fitting with the Boltzmann equation: , in which y is the inhibition ratio of increase in [Ca2+]c, A1 is the asymptotic maximum, A2 is the asymptotic minimum, x is concentrations of emodin and dx is the time constant.

Results

Emodin inhibited ATP-triggered increase in cytosolic Ca2+ concentrations in macrophages

The influence of emodin on ATP-induced [Ca2+]c increase was measured by Ca2+ imaging. A rise in F340/F380 ratio indicated an increase in [Ca2+]c. To activate P2X7R completely, a high concentration of ATP (5 mM) was chosen. Representative [Ca2+]c profiles are shown in . The application of ATP (indicated by arrows) triggered a rapid increase in [Ca2+]c, and this [Ca2+]c increase was significantly inhibited by pretreatment with different concentrations of emodin (0.1, 0.3, 1, 3, 10 µM) for 20 min. The inhibition was dependent on the dose of emodin. The peak values of [Ca2+]c increase were plotted against the concentration of emodin. As shown in , the peak values of ATP-induced [Ca2+]c increase were reduced by 26.9, 40.3, 69.8, 90.0 and 98.6% in the presence of 0.1, 0.3, 1, 3 and 10 μM emodin, respectively. The dose-dependent curve was fitted, with an IC50 of 0.5 μM. We also tested the effect of BBG, a potent P2X7R antagonist in parallel experiments as a positive control (Bulanova et al., Citation2005; Jiang et al., Citation2000). It can be seen from that the ATP-triggered increase in [Ca2+]c was remarkably reduced by different concentrations of BBG (0.1, 1, 10 µM). This inhibition of BBG indicated the involvement of P2X7R in [Ca2+]c increase triggered by ATP. In addition, emodin alone had no effect on [Ca2+]c at the same experimental conditions (data not shown). These results together indicated the efficient inhibitory effect of emodin on ATP-induced increase in [Ca2+]c, and this effect was dependent on antagonizing P2X7R.

Figure 1. Inhibition of emodin on ATP-evoked increase in [Ca2+]c in macrophages. (A) Representative [Ca2+]c traces for stimulating macrophages with ATP (5 mM) in the absence (control) and in the presence of emodin (0.1, 0.3, 1, 3, 10 µM). Emodin was added 20 min before the application of ATP. Arrows indicated the application of ATP. (B) The statistic peak values of increase in F340/F380 ratio after ATP application from experiments shown in A (n = 15 for each case). *p < 0.05 by one-way ANOVA, compared with control group. The smooth curve represented the fitting to the equation of with an IC50 value of 0.5 μM. (C) Representative [Ca2+]c traces for stimulating macrophages with ATP (5 mM) in the absence (control) and in the presence of BBG (0.1, 1, 10 µM). BBG was added 20 min before the stimulating with ATP.

Figure 1. Inhibition of emodin on ATP-evoked increase in [Ca2+]c in macrophages. (A) Representative [Ca2+]c traces for stimulating macrophages with ATP (5 mM) in the absence (control) and in the presence of emodin (0.1, 0.3, 1, 3, 10 µM). Emodin was added 20 min before the application of ATP. Arrows indicated the application of ATP. (B) The statistic peak values of increase in F340/F380 ratio after ATP application from experiments shown in A (n = 15 for each case). *p < 0.05 by one-way ANOVA, compared with control group. The smooth curve represented the fitting to the equation of with an IC50 value of 0.5 μM. (C) Representative [Ca2+]c traces for stimulating macrophages with ATP (5 mM) in the absence (control) and in the presence of BBG (0.1, 1, 10 µM). BBG was added 20 min before the stimulating with ATP.

Emodin reduced ATP-induced IL-1β release from LPS-activated macrophages

The following experiment examined ATP-induced IL-1β release from LPS-activated macrophages, and further evaluated whether emodin can inhibit the ATP-induced IL-1β secretion. As previously suggested (Sanz & Virgilio, Citation2000), macrophages were pretreated with 5 µg/ml LPS or LPS plus different doses of emodin (0.1, 0.3, 1, 3, 10 µM)/BBG (0.1, 1, 10 µM) for 5 h. Then, the cells were stimulated by 2 mM ATP for additional 2 h in the presence of LPS and emodin/BBG. As shown in , ATP evoked a massive secretion of IL-1β in LPS-primed macrophages (490.4 ±62.3 pg/ml, 6.4-fold increase compared with the basal level 76.5 ± 4.5 pg/ml in control). Moreover, emodin reduced the IL-1β release triggered by ATP in a concentration-dependent way with an IC50 of 1 μM. Similarly, BBG exhibited suppressive effects on IL-1β secretion. In addition, emodin alone had no effect on IL-1β secretion (78.1 ± 5.1 pg/ml). ATP or LPS alone cannot cause massive extracellular accumulation of IL-1β (85.6 ± 5.7 pg/ml and 124.0 ±11.1 pg/ml, respectively). Because ATP-induced IL-1β release from LPS-primed macrophages is directly associated with the activation of P2X7R (Ferrari et al., Citation2006; Kahlenberg & Dubyak, Citation2004), the data above suggested that emodin reduced ATP-induced IL-1β release by inhibiting the activation of P2X7 receptors.

Figure 2. Inhibition of emodin on IL-1β release induced by ATP in LPS-primed macrophages. Macrophages were pretreated with LPS (5 µg/ml) and emodin (0.1, 0.3, 1, 3, 10 µM) or BBG (0.1, 1, 10 µM) for 5 h simultaneously, then stimulated with ATP (2 mM) for an additional 2 h. IL-1β production in supernatants was measured by ELISA kits. The concentration of IL-1β (pg/ml) in each group was determined by the standard curve (n = 5 for each group). *p < 0.05 by Student’s t-test, compared with control group (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP plus LPS group.

Figure 2. Inhibition of emodin on IL-1β release induced by ATP in LPS-primed macrophages. Macrophages were pretreated with LPS (5 µg/ml) and emodin (0.1, 0.3, 1, 3, 10 µM) or BBG (0.1, 1, 10 µM) for 5 h simultaneously, then stimulated with ATP (2 mM) for an additional 2 h. IL-1β production in supernatants was measured by ELISA kits. The concentration of IL-1β (pg/ml) in each group was determined by the standard curve (n = 5 for each group). *p < 0.05 by Student’s t-test, compared with control group (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP plus LPS group.

Emodin suppressed ATP-evoked ROS production in macrophages

Next, the influence of emodin on ATP-evoked intracellular ROS production was detected with DHE fluorescent live imaging. As shown in , compared with control (cells treated with vehicle solution), the stimulation with ATP (1 mM) for 30 min induced a remarkable intracellular ROS generation, whereas treatment with emodin (10 µM) or BBG (10 µM) alone had no obvious effect (data not shown). Three hour pretreatment with emodin (0.1, 0.3, 1, 3, 10 µM) or BBG (0.1, 1, 10 µM) suppressed the ROS production evoked by ATP in a dose-dependent manner, respectively. The IC50 of emodin was 1.6 μM at this condition. Besides, ROS generation was inhibited by pretreatment for 3 h with two typical ROS scavengers, DPI (0.1, 1, 10 µM, a NAD(P)H oxidase inhibitor), and SOD (10, 100 U/ml), as positive control. Taken together, these results suggested the suppressive effect of emodin on ATP-induced ROS production, which was related to the activation of P2X7R.

Figure 3. Inhibition of emodin on ATP-induced ROS production in macrophages. (A) Dihydroethidium (DHE) fluorescence images, captured using a 40× objective, are shown. The fluorescence intensity represents the ROS concentration. The cells were pretreated with indicated concentration of BBG (0.1, 1, 10 µM), emodin (0.1, 0.3, 1, 3, 10 µM), DPI (0.1, 1, 10 µM) and SOD (10, 100 U/ml) for 3 h, and stimulated with ATP (1 mM) for additional 30 min. (B) Statistic data of the fluorescence intensity (n = 30). *p < 0.05 by Student’s t-test, compared with control group (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP alone group.

Figure 3. Inhibition of emodin on ATP-induced ROS production in macrophages. (A) Dihydroethidium (DHE) fluorescence images, captured using a 40× objective, are shown. The fluorescence intensity represents the ROS concentration. The cells were pretreated with indicated concentration of BBG (0.1, 1, 10 µM), emodin (0.1, 0.3, 1, 3, 10 µM), DPI (0.1, 1, 10 µM) and SOD (10, 100 U/ml) for 3 h, and stimulated with ATP (1 mM) for additional 30 min. (B) Statistic data of the fluorescence intensity (n = 30). *p < 0.05 by Student’s t-test, compared with control group (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP alone group.

Emodin inhibited ATP-induced phagocytosis attenuation of macrophages

Finally, the effects of emodin on ATP-evoked phagocytotic attenuation of macrophages were examined. The phagocytic ability of macrophages was represented by the uptake assay of neutral red. As shown in , compared with the control group (cells treated with vehicle solution), stimulation with ATP (1 mM) for 30 min evoked an obvious decrease in neutral red uptake, indicating phagocytotic attenuation of macrophages caused by ATP exposure. Three hour pretreatment with emodin (0.1, 0.3, 1, 3, 10 µM) counteracted this negative effect of ATP on the phagocytosis of macrophages in a concentration-dependent manner. The inhibition of BBG (0.1, 1, 10 µM) on decrease in neutral red uptake is shown in , supporting that P2X7R contributed to the phagocytosis attenuation induced by ATP. The influences of emodin or BBG on phagocytic activity of macrophages expressed as recovery rates are shown in , respectively. Pretreatment with 0.3, 1, 3 and 10 μM emodin increased the recovery to 37.4, 75.4, 94.8 and 96.7%, respectively (), and pretreatment with 0.1, 1 and 10 μM BBG increased the recovery to 19.9, 57.4 and 90.0%, respectively (). The IC50 value of emodin was 0.7 μM. These data indicated that emodin inhibited ATP-induced phagocytosis attenuation of macrophages, in which P2X7 receptors played an essential role.

Figure 4. Inhibition of emodin on ATP-induced phagocytosis decrease in macrophages. The phagocytic activity of macrophages was tested by a neutral red uptake assay. (A and B) Macrophages were pretreated with emodin (0.1, 0.3, 1, 3, 10 µM) or BBG (0.1, 1, 10 µM) for 3 h, and then stimulated simultaneously with ATP (1 mM) and neutral red (0.1%) for additional 30 min. The relative phagocytic activity in each group was represented by A550 (n = 5). *p < 0.05 by Student’s t-test, compared with control (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP alone group. (C and D) Statistic data of the recovery rates of phagocytic activity, which were derived from the calculation of . The recovery rates in C and D were calculated by the values of A550 given in A and B, respectively (n = 5). *p < 0.05 by Student’s t-test, compared with control; #p < 0.05 by one-way ANOVA, compared with ATP alone group.

Figure 4. Inhibition of emodin on ATP-induced phagocytosis decrease in macrophages. The phagocytic activity of macrophages was tested by a neutral red uptake assay. (A and B) Macrophages were pretreated with emodin (0.1, 0.3, 1, 3, 10 µM) or BBG (0.1, 1, 10 µM) for 3 h, and then stimulated simultaneously with ATP (1 mM) and neutral red (0.1%) for additional 30 min. The relative phagocytic activity in each group was represented by A550 (n = 5). *p < 0.05 by Student’s t-test, compared with control (cells treated with vehicle solution); #p < 0.05 by one-way ANOVA, compared with ATP alone group. (C and D) Statistic data of the recovery rates of phagocytic activity, which were derived from the calculation of . The recovery rates in C and D were calculated by the values of A550 given in A and B, respectively (n = 5). *p < 0.05 by Student’s t-test, compared with control; #p < 0.05 by one-way ANOVA, compared with ATP alone group.

Discussion

In our previous report, emodin can inhibit BzATP-triggered increases in [Ca2+]c, ATP-induced pore formation in rat peritoneal macrophages, and can suppress BzATP-evoked currents in HEK293 cells expressing P2X7R. These results supported a role of emodin as an antagonist of P2X7R (Liu et al., Citation2010). This study showed that emodin potently inhibited several P2X7R-related inflammation responses induced by ATP, the natural ligand of P2X7R, including [Ca2+]c increase, IL-1β release, ROS production and phagocytosis attenuation in rat macrophages.

In this study, it was found that emodin suppressed millimolar ATP-triggered increase of [Ca2+]c in a concentration-dependent manner, with an IC50 of 0.5 μM (). This value was the same with the IC50 of emodin (0.5 μM) in our previous work when using P2X7R agonist BzATP to simulate macrophages. Besides, the inhibitory effect of P2X7R antagonist BBG suggested that P2X7 receptors are responsible for ATP-induced [Ca2+]c increases (). Therefore, the inhibition of emodin on ATP-induced increase in [Ca2+]c is mediated by antagonizing P2X7R.

This study has also demonstrated that emodin dose-dependently suppressed the ATP-evoked massive secretion of IL-1β from LPS-activated macrophages, with an IC50 of 1 μM (). It has been established that P2X7R-dependent Ca2+ entry and K+ efflux play critical roles in ATP-induced IL-1β release (Ferrari et al., Citation2006; Kahlenberg & Dubyak, Citation2004). Our experiment with BBG confirmed the relationship between P2X7R and IL-1β processing. Therefore, the present results supported that the suppressive effects of emodin on ATP-induced IL-1β release was associated with inhibiting the activation of P2X7 receptors. Furthermore, this study showed that emodin reduced the ATP-induced ROS production and phagocytosis attenuation in a dose-dependent manner, with IC50 values of 1.6 and 0.7 μM, respectively ( and ). As reported, the activation of P2X7R is necessary for the generation of ROS and reduction of phagocytic activity triggered by millimolar ATP in macrophages (Fang et al., Citation2009; Fontanils et al., Citation2010; Moore & MacKenzie, Citation2009; Pfeiffer et al., Citation2007). The inhibitory effects of BBG in our experiment also verified the contribution of P2X7R to ROS production and phagocytosis attenuation ( and ), corroborating previous findings. These results suggested that P2X7 receptors contributed to the inhibition of emodin on ATP-induced ROS production and phagocytosis attenuation.

The significance of this study are that we demonstrated the inhibitory effects of emodin on inflammatory responses induced by extracellular ATP, and revealed a mechanism involving antagonizing P2X7R in rat peritoneal macrophages. Emodin has been used to treat inflammatory diseases since ancient times. It can inhibit lymphocyte proliferation and secretion of cytokines (IL-1, 2, 4, 6, tumor necrotic factor α and interferon γ) from immune cells (Budagian et al., Citation2003; Huang et al., Citation1991, Citation1992). Although the modulation of protein kinase C and protein tyrosine kinase are now considered to be implicated in these inhibitory effects of emodin, the precise mechanisms are largely unclear (Huang et al., Citation2004; Zhang & Hung, Citation1996). Some papers reported that many effects of emodin were critically depended on the P2X7 receptors (Aga et al., Citation2004; Bulanova et al., Citation2005), which play important roles in immune responses and inflammatory diseases (White & Burnstock, Citation2006; Zhou et al., Citation2006). Our results provide evidence for the anti-inflammatory and immunosuppressive activities of emodin and the underlying mechanisms related to P2X7 receptors. These discoveries may provide important insights into a target for related drug exploitation and diseases therapy.

Conclusion

In summary, we found in this study, emodin inhibited ATP-induced [Ca2+]c increases, IL-1β secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages. P2X7 receptors played a key role in these processes. These findings could provide some cellular basis for the anti-inflammatory activities of emodin, and may facilitate the development of therapeutic drugs targeting P2X7 receptors.

Declaration of interest

All authors state that they have no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The materials and methods described in this manuscript are available to scientists for purposes of replicating reported studies.

Acknowledgements

This study was supported by the Fundamental Research Funds for the Central Universities (No. 65010901). Sincere gratitude to Dr. Jie Zou for her technical assistance and Dr. Kun Song for his important comments.

References

  • Aga M, Watters JJ, Pfeiffer AZ. (2004). Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages. Am J Physiol Cell Physiol 286:C923–30
  • Budagian V, Bulanova E, Brovko L, et al. (2003). Signalling through P2X7 receptor in human T cells involved p65lck MAP kinases and transcription facrtors AP-1 and NF-кB. J Biol Chem 278:1549–60
  • Bulanova E, Budagian V, Orinska Z, et al. (2005). Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 174:3880–90
  • Coutinho-Silva R, Ojcius DM, Górecki DC, et al. (2005). Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem Pharmacol 69:641–55
  • Coutinho-Silva R, Persechini PM, Bisaggio RD, et al. (1999). P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol Cell Physiol 276:C1139–47
  • Ferrari D, Pizzirani C, Adinolfi E, et al. (2006). The P2X7 receptor: A key player in IL-1 processing and release. J Immunol 176:3877–83
  • Fontanils U, Seil M, Pochet S, et al. (2010). Stimulation by P2X7 receptors of calcium-dependent production of reactive oxygen species (ROS) in rat submandibular glands. Biochim Biophys Acta 1800:1183–91
  • Fang KM, Yang CS, Sun HS, Tzeng SF. (2009). Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X7 receptor action. J Neurochem 111:1225–37
  • Gu BJ, Saunders MB, Jursik C, Wiley SJ. (2010). The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood 115:1621–31
  • Huang HC, Chu SH, Chao PD. (1991). Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 198:211–13
  • Huang HC, Chang JH, Tung SF, et al. (1992). Immunosuppressive effect of emodin, a free radical generator. Eur J Pharmacol 18:359–64
  • Huang Q, Shen HM, Ong CN. (2004). Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 68:361–71
  • Hu F, Yang S, Zhao D, et al. (2012). Moderate extracellular acidification inhibits capsaicin-induced cell death through regulating calcium mobilization, NF-κB translocation and ROS production in synoviocytes. Biochem Biophys Res Commun 424:196–200
  • Jiang LH, Mackenzie AB, North RA, Surprenant A. (2000). Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors. Mol Pharmacol 58:82–8
  • Kahlenberg JM, Dubyak RG. (2004). Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Cell Physiol 286:1100–8
  • Kaneshiro T, Morioka T, Inamine M, et al. (2006). Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur J Pharmacol 553:46–53
  • Khakh BS, North RA. (2006). P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527–32
  • Liu LJ, Zou J, Liu X, et al. (2010). Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor. Eur J Pharmacol 640:15–19
  • Marques-da-Silva C, Burnstock G, Ojciusc DM, Coutinho-Silva R. (2011). Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiol 216:1–11
  • Moore FS, MacKenzie BA. (2009). NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxinprimed macrophages. J Immunol 183:3302–8
  • Man Y, Wang YX, Zhu SY, et al. (2012). Indirubin inhibits ATP-induced phagocytosis attenuation, ROS production and cell death of macrophages. Acta Pharmaceut Sin 47:45–50
  • Pfeiffer AZ, Guerra NA, Hill ML, et al. (2007). Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. Free Radic Biol Med 42:1506–16
  • Ralevic V, Burnstock G. (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50:413–92
  • Surprenant A, Rassendren F, Kawashima E, et al. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735–8
  • Sanz MJ, Virgilio DF. (2000). Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. Immunology 164:4893–8
  • Tsai T, Chen C. (1992). Ultraviolet spectrum identification of emodin in rabbit plasma by HPLC and its pharmacokinetics application. Asia Pac J Pharm 7:53–6
  • Tang T, Yin LW, Yang J, Shan G. (2007). Emodin, an anthraquinone derivative from Rheum officinale Baill, enhances cutaneous wound healing in rats. Eur J Pharmacol 567:177–85
  • White N, Burnstock G. (2006). P2 receptors and cancer. Trends Pharmacol Sci 27:211–17
  • Zhang L, Hung MC. (1996). Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 12:571–6
  • Zhou XY, Yang WX, Li JY. (2006). Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-κB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem 281:31337–47

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.